Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Molecular Cancer Therapeutics|September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)Ursula A Germann, Brinley F Furey, William Markland, et al.
Journal of Medicinal Chemistry|October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational controlAlex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
International Journal of Cardiology|June 21, 2025
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trialJose Luis Zamorano, Gabor Vörös, Valeria Calvi, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|April 3, 2020
Unintentional injuries in Mexico, 1990-2017: findings from the Global Burden of Disease Study 2017Martha Híjar, Ricardo Pérez-Núñez, Elisa Hidalgo-Solórzano, et al.
Nature|April 9, 2025
Small molecules restore mutant mitochondrial DNA polymerase activitySebastian Valenzuela, Xuefeng Zhu, Bertil Macao, et al.
Frontiers in Microbiology|November 8, 2017
Microbial Community and Biochemical Dynamics of Biological Soil Crusts across a Gradient of Surface Coverage in the Central Mojave DesertRakesh Mogul, Parag Vaishampayan, Mina Bashir, et al.
Journal of Medicinal Chemistry|August 1, 2015
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune DiseasesLuc J Farmer, Mark W Ledeboer, Thomas Hoock, et al.
Pageof 7